Diutensen-r

   
Google
 
Web NewDrugInformation.com

Diutensen-r


Drug - Diutensen-r
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methyclothiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 2.5MG;0.1MG
The potency of the active ingredient(s), Methyclothiazide; Reserpine. May repeat for multiple part products.

Applicant - MEDPOINTE PHARM HLC
The firm name holding legal responsibility for Diutensen-r. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012708
The FDA assigned number to Diutensen-r. Format is nnnnnn.

Product Number - 005
The FDA assigned number to identify Diutensen-r. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Diutensen-r was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Diutensen-r. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Diutensen-r is in. Format is RX, OTC, DISCN.

Applicant Full Name - Medpointe Pharmaceuticals Medpointe Healthcare Inc
The full name of the firm holding legal responsibility for the new application of Diutensen-r.

Diutensen-r